Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-6-20
pubmed:abstractText
Dutch-belted and New Zealand White rabbits were passively immunized with AVP-21D9, a human monoclonal antibody to protective antigen (PA), at the time of Bacillus anthracis spore challenge using either nasal instillation or aerosol challenge techniques. AVP-21D9 (10 mg/kg) completely protected both rabbit strains against lethal infection with Bacillus anthracis Ames spores, regardless of the inoculation method. Further, all but one of the passively immunized animals (23/24) were completely resistant to rechallenge with spores by either respiratory challenge method at 5 weeks after primary challenge. Analysis of the sera at 5 weeks after primary challenge showed that residual human anti-PA levels decreased by 85 to 95%, but low titers of rabbit-specific anti-PA titers were also measured. Both sources of anti-PA could have contributed to protection from rechallenge. In a subsequent study, bacteriological and histopathology analyses revealed that B. anthracis disseminated to the bloodstream in some naïve animals as early as 24 h postchallenge and increased in frequency with time. AVP-21D9 significantly reduced the dissemination of the bacteria to the bloodstream and to various organs following infection. Examination of tissue sections from infected control animals, stained with hematoxylin-eosin and the Gram stain, showed edema and/or hemorrhage in the lungs and the presence of bacteria in mediastinal lymph nodes, with necrosis and inflammation. Tissue sections from infected rabbits dosed with AVP-21D9 appeared comparable to corresponding tissues from uninfected animals despite lethal challenge with B. anthracis Ames spores. Concomitant treatment with AVP-21D9 at the time of challenge conferred complete protection in the rabbit inhalation anthrax model. Early treatment increased the efficacy progressively and in a dose-dependent manner. Thus, AVP-21D9 could offer an adjunct or alternative clinical treatment regimen against inhalation anthrax.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-10085028, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-11353060, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-11535328, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-11854261, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-12396928, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-12819066, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-12867985, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-12875989, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-15671576, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-15925272, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-15935874, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16141341, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16299324, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16368995, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16369003, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16417950, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16428748, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16785422, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16840255, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16923785, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-16988266, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-1730501, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-1903769, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-3148815, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-3917427, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-8460135, http://linkedlifedata.com/resource/pubmed/commentcorrection/17452469-9822127
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3414-24
pubmed:dateRevised
2011-5-25
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
pubmed:affiliation
Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1070, USA. johnny.peterson@utmb.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural